# Fibrinolysis Before Cardiopulmonary Bypass?

> **NCT01981863** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 40 (actual)

## Conditions studied

- Pathologic Fibrinolysis

## Interventions

- **DRUG:** Epsilonaminocaproic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01981863
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01981863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01981863, "Fibrinolysis Before Cardiopulmonary Bypass?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01981863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*